In summary, we have demonstrated that aberrantly activated mTORC1 contributes to ferroptosis resistance and tumor growth by regulating of the ERO1α/IL-6/STAT3/SLC7A11 signaling pathway (Fig. 8M). Here, IL6 is linked to neoplasm.